logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2011 or most recent year available

Part (ii) All outpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium3.84.22.01.01.03.55.11.83152
Bulgaria4.21.71.01.6:2.02.31.41461
Czech Republic2.24.01.70.5:0.32.50.52015
Denmark3.04.42.21.83.0:3.61.83625
Germany3.25.92.60.83.11.56.03.360114
Estonia3.0:1.6::4.03.7:532
Ireland2.35.02.91.65.01.25.32.65353
Greece6.16.32.22.60.5:5.60.73882
Spain15.36.34.51.76.723.06.32.053224
France3.43.92.81.37.83.26.42.234840
Italy25.28.52.60.53.90.910.82.542341
Cyprus6.217.813.01.7::9.9:813
Latvia33.76.03.31.27.59.312.63.31972
Lithuania:::::::::
Luxembourg2.0:::::::35
Hungary3.66.43.30.55.022.09.94.73703
Malta4.77.82.9:::6.61.51821
Netherlands4.75.43.51.64.55.03.51.011341
Austria2.65.64.11.63.0:4.93.52595
Poland44.510.05.40.60.0:6.04.3788
Portugal55.23.71.30.8::6.34.03764
Romania4.4::1.0::10.06.5749
Slovenia4.12.00.01.0::2.70.0521
Slovakia63.3:3.11.6:20.011.1:722
Finland1.6:1.22.4:0.03.10.7908
Sweden:::::::::
United Kingdom72.83.61.91.72.11.43.51.9107369
Croatia84.67.35.31.9::7.2:7102
Turkey:::::::::
Norway92.24.32.10.91.80.03.12.44896
Total3.55.42.41.32.82.45.22.43.9
Total base17254956808171747763958777989164693359638
 

Notes:

Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented.

1 - Data are from 2010.

2 - In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

3 - In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

4 - Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

5 - In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Other substances includes patients with alcohol and tobacco.

6 - 6 Cocaine Male clients reported

7 - Data are from 1st of April 2010 to 31st March 2011.

8 - For Other Drugs 16 Male clients reported.

9 - In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

For more information relative to the treatment centre type, please see Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — TDI — outpatient treatment centres.

Page last updated: Friday, 26 April 2013